Abstract:Background and aims Endoscopic full-thickness resection (EFTR) has been increasingly applied in the treatment of gastric submucosal tumors (G-SMTs) with explorative intention. This study aimed to compare the efficacy, tolerability, and clinical outcomes of EFTR and surgical intervention for the management of muscularis propria (MP)-derived G-SMTs. Methods Between September 2011 and May 2019, the clinical records of patients with MP-derived G-SMTs undergoing EFTR at our endoscopic unit were collected. A cohort of people with primary MP-derived G-SMTs treated by surgery was matched in a 1:1 ratio to EFTR group with regard to patients’ baseline characteristics, clinicopathologic features of the tumor and the procedure date. The perioperative outcomes and follow-up data were analyzed. Results In total, 62 and 62 patients were enrolled into the surgery and EFTR group, respectively, with median follow-up of 786 days. The size of G-SMTs (with ulceration) ranged from 10 to 90 mm. For patients with tumor smaller than 30 mm, surgery and EFTR group presented comparable procedural success rate (both were 100%), en bloc resection rate (100% vs. 94.7%), tumor capsule rupture rate (0% vs. 5.3%), and pathological R0 resection rate (both were 100%). EFTR had a statistically significant advantage over surgery for estimated blood loss (3.12 ± 5.20 vs. 46.97 ± 60.73 ml, p ≤ 0.001), discrepancy between the pre- and postprocedural hemoglobin level (5.18 ± 5.43 vs. 9.84 ± 8.25 g/L, p = 0.005), bowel function restoration [1 (0–5) vs. 3 (1–5) days, p ≤ 0.001], and hospital cost (28,617.09 ± 6720.78 vs. 33,963.10 ± 13,454.52 Yuan, p = 0.033). The patients with tumor larger than 30 mm showed roughly the same outcomes after comparison analysis of the two groups. However, the clinical data revealed lower en bloc resection rate (75.0% vs. 100%, p = 0.022) and higher tumor capsule rupture rate (25.0% vs. 0%, p = 0.022) for EFTR when compared to surgery. The procedure time, duration of postprocedural fasting and antibiotics usage, and hospital stay of the two groups were equivalent. The occurrence rate of adverse events within postoperative day 7 were 74.2% and 72.6% after EFTR and surgery, respectively ( p = 1.000). No complications occurred during the follow-up. Conclusion For treatment of MP-derived G-SMTs (with or without ulceration), our study showed the feasibility and safety of EFTR, which also provided better results in terms of procedural blood loss, the postoperative bowel function restoration and cost-effectiveness when compared to surgery, whereas the surgery was superior in en bloc resection rate for G-SMTs larger than 30 mm. The postprocedural clinical outcomes seemed to be equivalent in these two resection methods.

Endoscopic submucosal dissection of gastric plexiform fibromyxoma, an alternative to the traditional approach

Endoscopic Submucosal Dissection for the Treatment of Large Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single Center Study.

Laparoscopy endoscopy cooperative surgery for gastric plexiform fibromyxoma: a case report

Gastric Plexiform Fibromyxoma Resected Using Nonexposed Endoscopic Wall-Inversion Surgery: A Case Report

Endoscopic submucosal excavation for gastric plexiform fibromyxoma: A case report and systematic review of literature

Antral plexiform fibromyxoma: case report of a rare mesenchymal neoplasm

Comparison of Endoscopic Submucosal Dissection and Surgery for the Treatment of Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single-Center Study (with Video)

Resection of the Gastric Submucosal Tumor (G-SMT) Originating from the Muscularis Propria Layer: Comparison of Efficacy, Patients' Tolerability, and Clinical Outcomes Between Endoscopic Full-Thickness Resection and Surgical Resection

A case of asymptomatic gastric plexiform fibromyxoma followed up for 3 years

Gastric plexiform fibromyxoma, an uncommon mesenchymal tumor

Plexiform fibromyxoma: Case report and literature review

Plexiform Fibromyxoma: A Rare Gastric Tumor

A case of gastric plexiform fibromyxoma: radiological and pathological findings

Rare mesenchymal antral gastric tumors: Case reports of glomus tumor and plexiform fibromyxoma

Rarity among benign gastric tumors: Plexiform fibromyxoma - Report of two cases

Combining Endoscopic Submucosa Dissection and Endoscopic Full-Thickness Resection for Resection of a Gastric Schwannoma Mimicking Gastrointestinal Stroma Tumor

Plexiform fibromyxoma of the small bowel: A case report

An Esophageal Submucosal Tumor Treated with Submucosal Tunneling Endoscopic Resection: an Unexpected Result

ID: 3527921 ENDOSCOPIC INTRAPERITONEAL SUBSEROSAL DISSECTION (EISD): BETTER VIEW, SAFER OPERATION

Endoscopic ultrasound FNA: An illustrated review of spindle cell neoplasms of the upper gastrointestinal tract including a novel case of gastric plexiform fibromyxoma

A rare case of plexiform fibromyxoma in stomach: FNA diagnosis with histological correlation and differential diagnoses